Managing your inbox is a never-ending task, which is why we should seek to simplify it as much as possible. When emails pile up, you start overthinking what you need to do—I know I do, anyway. But if ...

Many years ago, I saw a tweet go around that said something like, "You have the same amount of hours in a day as Beyoncé." On the one hand, that was annoying, because while it’s true, I don’t have the ...

Shunting in NPH, a novel drug for narcolepsy, and new approaches in multiple sclerosis are among the top picks from Professor Diener.

AstraZeneca aims for $80bn revenue by 2030, highlighting oncology advances and growth potential. See AZN stock's valuation insights and GARP investment case.

Novartis has tapped up an artificial-intelligence-enabled British biotech for a $1.7 billion biobucks deal to discover new targets for immuno-dermatology conditions. What caught the Swiss pharma’s eye ...